Molecular markers for targeted therapy
Molecular Markers for Targeted Therapy What are they? Molecular markers are specific genes or genetic sequences that are altered in cancer cells. These a...
Molecular Markers for Targeted Therapy What are they? Molecular markers are specific genes or genetic sequences that are altered in cancer cells. These a...
What are they?
Molecular markers are specific genes or genetic sequences that are altered in cancer cells. These alterations can be detected through various techniques, allowing doctors to identify and target cancer cells with high precision.
Examples:
Mutational profiling: This technique analyzes the genetic makeup of a tumor and identifies specific mutations that are commonly found in cancer cells.
Gene expression analysis: This technique measures how genes are expressed in cancer cells. Alterations in gene expression can indicate cancer development and progression.
Chromosomal aberrations: These are large-scale changes in the chromosome that are common in certain types of cancer.
How are they used?
Molecular markers are used in various ways for targeted therapy:
Targeted therapy drugs: These drugs specifically bind to molecules found on the surface of cancer cells and block their function, leading to cell death.
Immunotherapy: This approach uses the patient's own immune system to recognize and attack cancer cells.
Gene therapy: This technique replaces faulty genes in cancer cells with functional ones, potentially curing the disease.
Benefits:
Precision treatment: Targeting cancer cells with high specificity reduces the risk of side effects on healthy tissues.
Early detection: Identifying genetic alterations in tumors allows for early diagnosis and treatment, increasing the chances of successful outcomes.
Combination therapies: Combining molecular markers with conventional therapies can provide synergistic effects and improve treatment outcomes.
Challenges:
Limited availability: Some molecular markers are rare or difficult to detect, limiting the availability of targeted therapies.
Drug resistance: Cancer cells can develop resistance to molecular markers and targeted therapies over time.
Individualized medicine: Effective molecular markers and targeted therapies require a thorough understanding of the patient's specific tumor and overall health.
Conclusion:
Molecular markers provide valuable tools for targeted therapy in surgical oncology. By understanding genetic alterations and utilizing specific techniques to detect and manipulate these markers, doctors can achieve precise and effective cancer treatment while minimizing harm to healthy tissues